Inventor profile of:

Barbara Langen

City:

Radebeul

Country:

Germany

Published Applications:

14

Last publication date:

2018-10-04

Top Assignees for applications by Barbara Langen

The entities that hold a legal rights for patent applications filed by inventor Langen Barbara:

Recent patent applications by Langen Barbara

Barbara Langen from Radebeul, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-10-04
US20180282305A1
Chemistry; metallurgy

Triazoles as NR2B receptor inhibitors

#2 | 2017-09-28
US20170275254A1
Chemistry; metallurgy

Pyrazoles

#3 | 2017-08-10
US20170226087A1
Chemistry; metallurgy

Triazoles as NR2B receptor inhibitors

#4 | 2014-02-13
US20140045857A1
Chemistry; metallurgy

Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders

#5 | 2012-11-29
US20120302564A1
Chemistry; metallurgy

(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases

#6 | 2010-05-13
US20100120763A1
Chemistry; metallurgy

IMIDAZO[5,1-C][1,2,4]BENZOTRIAZINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES

#7 | 2010-05-13
US20100120762A1
Chemistry; metallurgy

Triazine derivatives as inhibitors of phosphodiesterases

#8 | 2009-09-24
US20090239874A1
Chemistry; metallurgy

Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them

#9 | 2009-06-04
US20090143392A1
Human necessities

Methods of Treating Obesity and Metabolic Disorders

#10 | 2009-06-04
US20090143391A1
Chemistry; metallurgy

Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10

#11 | 2009-06-04
US20090143367A1
Chemistry; metallurgy

Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders

#12 | 2009-06-04
US20090143361A1
Chemistry; metallurgy

Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10

#13 | 2008-05-15
US20080114032A1
Human necessities

Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor

#14 | 2008-01-31
US20080027064A1
Chemistry; metallurgy

Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them

InventorID:

1952390 ⎘